NDC Package 83860-025-01 Vykat Xr

Diazoxide Choline Tablet, Film Coated Oral - View Billable Units, 11-Digit Format, RxNorm

Package Information

Find all the important details about this NDC Package code, including the 11-Digit NDC Billing number, billing units, wholesale price, RxNorm crosswalk, active ingredients, pharmacologic clasess, etc.

NDC Package Code:
83860-025-01
Package Description:
30 TABLET, FILM COATED in 1 BOTTLE
Product Code:
Proprietary Name:
Vykat Xr
Non-Proprietary Name:
Diazoxide Choline
Substance Name:
Diazoxide Choline
Usage Information:
VYKAT XR is indicated for the treatment of hyperphagia in adults and pediatric patients 4 years of age and older with Prader-Willi syndrome (PWS).
11-Digit NDC Billing Format:
83860002501
Billing Unit:
EA - Billing unit of "each" is used when the product is dispensed in discreet units.
NDC to RxNorm Crosswalk:
30 EA
NDC to RxNorm Crosswalk:
  • RxCUI: 2711548 - diazoxide choline 150 MG 24HR Extended Release Oral Tablet
  • RxCUI: 2711548 - 24 HR diazoxide choline 150 MG Extended Release Oral Tablet
  • RxCUI: 2711548 - diazoxide choline 150 MG 24 HR Extended Release Oral Tablet
  • RxCUI: 2711556 - vykat XR 150 MG 24HR Extended Release Oral Tablet
  • RxCUI: 2711556 - 24 HR diazoxide choline 150 MG Extended Release Oral Tablet [Vykat]
Product Type:
Human Prescription Drug
Labeler Name:
Soleno Therapeutics, Inc.
Dosage Form:
Tablet, Film Coated - A solid dosage form that contains medicinal substances with or without suitable diluents and is coated with a thin layer of a water-insoluble or water-soluble polymer.
Administration Route(s):
Oral - Administration to or by way of the mouth.
Active Ingredient(s):
Sample Package:
No
FDA Application Number:
NDA216665
Marketing Category:
NDA - A product marketed under an approved New Drug Application.
Start Marketing Date:
03-26-2025
Listing Expiration Date:
12-31-2026
Exclude Flag:
N
Code Structure:

The NDC Directory contains ONLY information on final marketed drugs submitted to FDA electronically by labelers. A labeler might be a manufacturer, re-packager or re-labeler. The product information included in the NDC directory does not indicate that FDA has verified the information provided by the product labeler. Assigned NDC numbers are not in any way an indication of FDA approval of the product.

* Please review the disclaimer below.

Frequently Asked Questions

What is NDC 83860-025-01?

The NDC Packaged Code 83860-025-01 is assigned to a package of 30 tablet, film coated in 1 bottle of Vykat Xr, a human prescription drug labeled by Soleno Therapeutics, Inc.. The product's dosage form is tablet, film coated and is administered via oral form.This product is billed for "EA" each discreet unit and contains an estimated amount of 30 billable units per package.

Is NDC 83860-025 included in the NDC Directory?

Yes, Vykat Xr with product code 83860-025 is active and included in the NDC Directory. The product was first marketed by Soleno Therapeutics, Inc. on March 26, 2025 and its listing in the NDC Directory is set to expire on December 31, 2026 if the product is not updated or renewed by the manufacturer.

What is the NDC billing unit for package 83860-025-01?

The contents of this package are billed per "each", products billed on a per each basis are usually products dispensed in discreet units. The calculated billable units for this package is 30.

What is the 11-digit format for NDC 83860-025-01?

The 11-digit format is 83860002501. The 11-digit billing format might be required by the Centers for Medicare & Medicaid Services (CMS) and other payers in billing claim forms.

This package code is originally configured in a 5-3-2 segment 10-digit format and by adding a zero within the original NDC package code we can obtain the converted 11-digit format in a 5-4-2 segment configuration. The table below shows the 11-digit code conversion:

10-Digit Format10-Digit Original Code11-Digit Format11-Digit Code
5-3-283860-025-015-4-283860-0025-01